IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

COLOMBO, CARLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.550
NA - Nord America 6.315
EU - Europa 6.042
Continente sconosciuto - Info sul continente non disponibili 737
SA - Sud America 695
AF - Africa 167
OC - Oceania 87
Totale 20.593
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.912
IT - Italia 2.211
CN - Cina 1.794
SG - Singapore 1.681
GB - Regno Unito 1.147
BD - Bangladesh 739
DE - Germania 649
HK - Hong Kong 515
BR - Brasile 477
VN - Vietnam 410
RU - Federazione Russa 339
IN - India 336
SE - Svezia 265
NL - Olanda 228
FR - Francia 226
CA - Canada 217
TR - Turchia 217
KR - Corea 188
ES - Italia 153
FI - Finlandia 151
JP - Giappone 119
ID - Indonesia 117
PL - Polonia 111
IE - Irlanda 100
MX - Messico 96
IR - Iran 75
AU - Australia 73
DK - Danimarca 67
AR - Argentina 59
UA - Ucraina 59
RO - Romania 56
GR - Grecia 51
CO - Colombia 49
PK - Pakistan 44
TW - Taiwan 44
EC - Ecuador 43
EG - Egitto 42
CI - Costa d'Avorio 39
BE - Belgio 38
PH - Filippine 32
TH - Thailandia 32
IQ - Iraq 31
MY - Malesia 28
CH - Svizzera 26
AT - Austria 25
MA - Marocco 25
UZ - Uzbekistan 24
HU - Ungheria 21
PE - Perù 21
SA - Arabia Saudita 21
CL - Cile 19
CR - Costa Rica 18
ZA - Sudafrica 18
PT - Portogallo 17
RS - Serbia 15
LU - Lussemburgo 14
AE - Emirati Arabi Uniti 13
DZ - Algeria 13
EU - Europa 13
JM - Giamaica 13
JO - Giordania 13
NZ - Nuova Zelanda 13
VE - Venezuela 13
CZ - Repubblica Ceca 12
HR - Croazia 12
NP - Nepal 11
LB - Libano 9
PA - Panama 8
PR - Porto Rico 8
SK - Slovacchia (Repubblica Slovacca) 8
AL - Albania 7
IL - Israele 7
LV - Lettonia 7
AZ - Azerbaigian 6
GT - Guatemala 6
HN - Honduras 6
KE - Kenya 6
KW - Kuwait 6
PY - Paraguay 6
BG - Bulgaria 5
BH - Bahrain 5
CU - Cuba 5
CY - Cipro 5
LT - Lituania 5
NG - Nigeria 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
BS - Bahamas 4
BZ - Belize 4
LA - Repubblica Popolare Democratica del Laos 4
LY - Libia 4
MM - Myanmar 4
NI - Nicaragua 4
NO - Norvegia 4
SC - Seychelles 4
EE - Estonia 3
ET - Etiopia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
Totale 19.827
Salva come PNG Salva come JPEG
Città #
Singapore 1.005
Southend 907
Ashburn 719
Milan 540
Hong Kong 428
San Jose 385
Santa Clara 318
Council Bluffs 305
Chandler 291
Beijing 257
Frankfurt am Main 257
Dallas 245
Los Angeles 215
New York 190
Wilmington 157
Rome 152
Fairfield 136
Hefei 136
Ho Chi Minh City 120
Seattle 107
Guangzhou 106
Hanoi 106
Houston 103
Princeton 103
Boardman 101
Dublin 99
Shanghai 99
Helsinki 97
Ann Arbor 94
Buffalo 88
Woodbridge 88
Istanbul 85
Redwood City 80
Bengaluru 76
Seoul 76
Jakarta 74
Lauterbourg 73
Tokyo 72
Bologna 70
Moscow 70
Toronto 70
Nanjing 64
Turin 57
Cambridge 55
Chicago 55
Naples 53
Florence 52
Munich 49
São Paulo 48
Hangzhou 47
The Dalles 44
Phoenix 42
Jinan 41
Des Moines 40
Abidjan 39
Dearborn 39
Columbus 37
Nuremberg 36
Kent 35
Athens 34
Atlanta 34
Pisa 33
Palermo 32
Warsaw 32
Washington 31
London 30
Bari 29
Tianjin 29
Sydney 28
Barcelona 27
San Diego 27
Brussels 26
Jacksonville 26
Berlin 25
Changsha 25
Shenyang 25
Denver 24
Düsseldorf 24
Mexico City 24
Montreal 24
Seongnam-si 24
Shenzhen 24
Ankara 23
Brooklyn 22
Central 22
Chennai 22
Madrid 22
Cangzhou 21
Charlotte 21
Hyderabad 21
Mountain View 21
Fuzhou 20
Redmond 20
Zhengzhou 20
Bangkok 19
Cagliari 19
Da Nang 19
Mumbai 19
Tashkent 19
Bühl 18
Totale 10.538
Salva come PNG Salva come JPEG
Nome #
Diet as a possible influencing factor in thyroid cancer incidence: the point of view of the nutritionist 1.525
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma. 722
Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission Probability 698
Genetic diagnosis of endocrine diseases by NGS: novel scenarios and unpredictable results and risks 671
Molecular markers for the classification of cytologically indeterminate thyroid nodules. 549
MICROCHIMERISMO CELLULARE FETALE NEL CARCINOMA PAPILLARE DELLA TIROIDE: ANALISI SU TESSUTI E SU SANGUE PERIFERICO 439
Clinical and molecular analyses of thyroid cancer in patients treated for benign diseases 358
Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment 348
Primary Adrenal Insufficiency during Lenvatinib or Vandetanib and Improvement of Fatigue after Cortisone Acetate Therapy 335
Poorly differentiated thyroid carcinoma: molecular, clinico-pathological hallmarks and therapeutic perspectives 325
Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients 319
The thyroid risk score (TRS) for nodules with indeterminate cytology 311
Management of hypertension during Lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm 289
Multicellular spheroids from normal and neoplastic thyroid tissues as a suitable model to test the effects of multikinase inhibitors 280
Fetal cell microchimerism : a protective role in autoimmune thyroid diseases 279
Thyroid cancer harboring PTEN and TP53 mutations: A peculiar molecular and clinical case report 267
Telomerase in differentiated thyroid cancer : promoter mutations, expression and localization 260
Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers ≤2 cm 250
BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer 250
MassARRAY-based simultaneous detection of hotspot somatic mutations and recurrent fusion genes in papillary thyroid carcinoma : the PTC-MA assay 244
Fetal cell microchimerism in papillary thyroid cancer : studies in peripheral blood and tissues 236
Refining calcium test for the diagnosis of medullary thyroid cancer : cutoffs, procedures, and safety 235
Papillary thyroid carcinoma and infammation 234
The molecular and gene/miRNA expression profiles of radioiodine resistant papillary thyroid cancer 234
Fetal cell microchimerism in papillary thyroid cancer : a role in the outcome of the disease 233
Impact of estrogen and progesterone receptors expression on the clinical and molecular features of papillary thyroid cancer 232
The tight relationship between papillary thyroid cancer, autoimmunity and inflammation : clinical and molecular studies 231
Combined Mutational and Clonality Analyses Support the Existence of Intra-Tumor Heterogeneity in Papillary Thyroid Cancer 231
The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma : functional characterization and expression/penetrance studies 226
Oxidative Stress Correlates with More Aggressive Features in Thyroid Cancer 224
Persistent Thyroid Carcinoma and Pregnancy: Outcomes in an Italian Series and Review of the Literature 224
Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers 223
Tumor and normal thyroid spheroids : from tissues to zebrafish 221
High Prevalence and Conservative Management of Acute Cholecystitis during Lenvatinib for Advanced Thyroid Cancer 220
TP53 Alterations Associate with Poor Response to Lenvatinib in Patients with Advanced Thyroid Cancer 218
Genetic variants of PARP4 gene and PARP4P2 pseudogene in patients with multiple primary tumors including thyroid cancer. 217
Are pre-miR-146a and PTTG1 associated with papillary thyroid cancer? 214
Vitamin D levels and lipid profile in children and adolescents: a tight correlation 211
FAM83B is involved in thyroid cancer cell differentiation and migration 205
Endocrine-related adverse conditions induced by tyrosine kinase inhibitors. 202
Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer 194
Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines 190
Body Composition and Leptin/Ghrelin Levels during Lenvatinib for Thyroid Cancer 187
Polycystic ovary syndrome and thyroid disorder: a comprehensive narrative review of the literature 183
Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy 182
Hypocalcemia During Lenvatinib Treatment for Advanced Thyroid Cancer: Clinical Features and Management in a Real-Life Setting 179
Post-surgical ablative or adjuvant radioiodine therapy has no impact on outcome in 1–4 cm differentiated thyroid cancers without extrathyroidal extension 176
Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer 174
L’apporto della biologia molecolare nel follow-up del tumore differenziato della tiroide (rassegna) 172
Il carcinoma della tiroide nell’anziano: terapia e follow-up 172
Targeting the DNA damage response kinase Chk1 in TP53-mutated aggressive thyroid cancers: in vitro studies 168
Lenvatinib as first-line treatment for advanced thyroid cancer: long progression-free survival 167
Inactivating mutations of TP53 and resistence to tyrosine-kinase inhibitors in patients affected with aggressive thyroid cancer 166
Daily Management of Patients on Multikinase Inhibitors' Treatment 165
Letter regarding the article: "Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls" by Kern et al 163
Absence of the MAP2K5 germline variants c.G961A and c.T1100C in a wide series of familial nonmedullary thyroid carcinoma Italian families 161
Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2) : insights from a large series of familial non-medullary thyroid cancers and literature review 155
Thyroid cancer and endocrine disruptive chemicals: a case–control study on per-fluoroalkyl substances and other persistent organic pollutants 152
Fetal microchimerism in women with thyroid cancer 152
Extra-nuclear TERT counteracts oxidative stress and promotes progression in papillary thyroid carcinoma 149
Fetal cell microchimerism in women with thyroid cancer 148
Small Bowel Neuroendocrine Tumors: Focus on Pathologic Aspects and Controversial Surgical Issues 146
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants 145
Impact of systemic treatments for advanced thyroid cancer on the adrenal cortex 139
ASO Author Reflections: Total Thyroidectomy Versus Lobectomy for Differentiated Thyroid Cancer 135
Oxidative stress and the subcellular localization of the telomerase reverse transcriptase (TERT) in papillary thyroid cancer 134
La lobectomia come trattamento iniziale del carcinoma midollare tiroideo sporadico: uno studio prospettico 133
Personalized treatment for differentiated thyroid cancer: current data and new perspectives 131
The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer 128
The impact of vitamin D status on lipid profiles and atherogenic dyslipidemia markers in children and adolescents with obesity 127
Lenvatinib-induced hypocalcaemia due to transient primary hypoparathyroidism 126
Impatto della dose iniziale sul trattamento con lenvatinib nel carcinoma tiroideo differenziato avanzato 124
BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer 123
Letter to the Editor: Tumor Lysis Syndrome During Selpercatinib Treatment in a Patient with Medullary Thyroid Cancer 122
Targeting the DNA damage response kinase CHK1 in TP53-mutated thyroid cancer: in vitro studies 116
Navigating the complexity of current interventional radiological approaches for distant metastases in thyroid cancer 114
Clinical relevance of the thyroid differentiation score (TDS) in benign and malignant thyroid tumors 109
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment 103
Basal and stimulated calcitonin levels in patients with type 2 diabetes did not change during 1 year of Liraglutide treatment 96
Improve knowledge and management of thyroid cancer: the role of the endocrinologist in a multidisciplinary team 92
Vitamin D, adiposity, and cardiometabolic risk: Insights from a multivariable cross-sectional study 92
Endocrinological toxicities related to immunotherapy combinations for advanced renal cell carcinoma: Practical expert-based management recommendations 91
Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows 90
A randomized controlled trial to evaluate the effects of topical intraoperative corticosteroid application on voice quality in thyroid surgery with preserved recurrent laryngeal nerves 85
The diagnostic puzzle of thyroid paraganglioma: when the usual suspects fail—a case report 79
Fibrosis‐Driven Surgical Risk After Thyroid Nodule Ablation: Quantitative Clinicopathological Determinants of Complications in Post‐Ablative Thyroidectomy—A Retrospective Cohort Study 78
Carbon Nanoparticle Technology for Parathyroid Gland Preservation during Thyroid Surgery: A Narrative Review 77
Artificial Intelligence and Intraoperative Neural Monitoring in Thyroid Surgery: A Review 76
When cytology misses and ultrasound warns: the predictive role of BRAFV600E mutation in thyroid nodules 71
Patient-Derived in Vitro Models Reveal Insights into Medullary Thyroid Cancer Microenvironment and Resistance to Tyrosine Kinase Inhibitors 67
Applicazione dell’Intelligenza Artificiale nella predizione delle complicanze postoperatorie nella chirurgia tiroidea: una revisione sistematica e meta-analisi della letteratura 63
Impatto dell’obesità sugli esiti della tiroidectomia: revisione sistematica della letteratura e meta-analisi 60
Simulation unlocked: transforming thyroid surgery training through high-fidelity and curriculum-based innovation-a systematic review 55
Value‐Based Neuromonitoring in Thyroidectomy: A Comprehensive Cost–Utility Analysis 51
Genetic modification of the AJCC classification of papillary thyroid cancer: an international, multicentre, retrospective cohort study. 45
Ten Years After TOETVA: Why Did We Abandon the Transoral Route? 44
Teaching parathyroid-sparing thyroidectomy: clinical and educational impact of near-infrared autofluorescence. Results of a retrospective case-control study 43
High-dose intravenous methylprednisolone is effective in subacute thyroiditis unresponsive to oral steroids 40
Physical activity and systemic treatment outcomes in advanced thyroid cancer. 33
The CHK1 inhibitor Prexasertib is effective against in vitro models of aggressive thyroid carcinomas with defective p53 function 26
Totale 20.354
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.818
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022886 0 0 49 66 73 75 72 55 143 91 73 189
2022/20231.612 161 148 130 114 147 224 84 115 155 79 157 98
2023/20241.891 104 143 90 176 345 124 133 129 110 148 193 196
2024/20253.263 160 267 133 239 284 218 188 306 251 350 299 568
2025/20267.641 622 486 612 451 608 408 852 356 639 629 1.037 941
2026/20271.489 849 606 34 0 0 0 0 0 0 0 0 0
Totale 20.593